MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia

BACKGROUND: Fludarabine, is one of the most active single agents in the treatment of chronic lymphocytic leukemia (CLL). Over time, however, virtually all CLL patients become fludarabine-refractory. To elucidate whether microRNAs are involved in the development of fludarabine resistance, we analyzed...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ferracin, Manuela, Zagatti, Barbara, Rizzotto, Lara, Cavazzini, Francesco, Veronese, Angelo, Ciccone, Maria, Saccenti, Elena, Lupini, Laura, Grilli, Andrea, De Angeli, Cristiano, Negrini, Massimo, Cuneo, Antonio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2010
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2892453/
https://ncbi.nlm.nih.gov/pubmed/20504344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-9-123
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller